National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1225005

History of Changes from the VAERS Wayback Machine

First Appeared on 7/2/2021

VAERS ID: 1225005
VAERS Form:2
Age:
Sex:Male
Location:Foreign
Vaccinated:2021-03-23
Onset:2021-03-26
Submitted:0000-00-00
Entered:2021-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP9605 / UNK - / -

Administered by: Other      Purchased by: ??
Symptoms: Sudden death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2021-03-26
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ASAFLOW; INEGY; LISINOPRIL; SINTROM; TARDYFERON; TENORMIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Angioplasty (angioplasty stenting); Ischemic heart disease; Myocardial necrosis (patient with a history of antero-septal myocardial necrosis); Thrombocytopenia
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': BEPFIZER INC2021398715

Write-up: Sudden death during an effortless walk this 26mar2021 after the vaccine no adverse effects before, no complaints before the walk; This is as spontaneous report received from a contactable physician downloaded from the Regulatory Authority-WEB. The regulatory authority report number BE-FAMHP-DHH-N2021-86449. A 72-year-old male patient received bnt162b2 (COMIRNATY, Lot Number: EP9605), via an unspecified route of administration on 23Mar2021 13:30 as single dose for COVID-19 immunization. Medical history included ischemic heart disease, antero-septal myocardial necrosis, angioplasty stenting, and stable isolated thrombocytopenia, all from an unknown date. Concomitant medications included acetylsalicylic acid (ASAFLOW), ezetimibe, simvastatin (INEGY), lisinopril, acenocoumarol (SINTROM), ferrous sulfate (TARDYFERON), and atenolol (TENORMIN) all taken for an unspecified indication, start and stop date were not reported. The patient experienced sudden death during an effortless walk this 26Mar2021 after the vaccine no adverse effects before, no complaints before the walk. The patient died on 26Mar2021. It was not reported if an autopsy was performed. Reporter comment: Treatment - Evolution of the ADR - Death. Relatedness of drug to reaction(s)/event(s): Source of assessment: Health Agency. Method of assessment: WHO. Result of Assessment : unclassifiable. No follow-up attempts are possible. No further information is expected.; Reporter''s Comments: Treatment - Evolution of the ADR - Death. Relatedness of drug to reaction(s)/event(s): Source of assessment: Health Agency. Method of assessment: WHO. Result of Assessment : unclassifiable.; Reported Cause(s) of Death: sudden death

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1225005&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166